In 2005 was created Vickers Venture Partners, which is appeared as VC. The venture was found in Asia in Singapore. The leading representative office of defined VC is situated in the Singapore.
The top activity for fund was in 2019. The increased amount of exits for fund were in 2019. The typical startup value when the investment from Vickers Venture Partners is more than 1 billion dollars. The fund is constantly included in 2-6 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 35 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Vickers Venture Partners performs on 24 percentage points less the average number of lead investments.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in some founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Software, Mobile. Among the most popular portfolio startups of the fund, we may highlight Samumed, Skyroam, Chooch AI.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Vickers Venture Partners, startups are often financed by GSR Ventures, Wavemaker Partners, SPH Media Fund. The meaningful sponsors for the fund in investment in the same round are GSR Ventures, Wavemaker Partners, WI Harper Group. In the next rounds fund is usually obtained by JAFCO Asia, GSR Ventures, Wavemaker Partners.
We also calculated 6 valuable employees in our database.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Mithradote Bio | 02 Oct 2024 | San Diego, California, United States | |||
Aardvark Therapeutics | $85M | 09 May 2024 | San Diego, California, United States | ||
Eavor | $144M | 25 Oct 2023 | Calgary, Canada | ||
AWAK Technologies | $20M | 13 Sep 2023 | Burbank, California, United States | ||
Eavor | $63M | 14 Jun 2023 | Calgary, Canada | ||
Qianyuhui Environmental Protection | 24 Nov 2022 | Dongcheng, Shaanxi, China | |||
RWDC Industries | $95M | 22 Nov 2021 | Singapore, Central, Singapore | ||
Aardvark Therapeutics | $29M | 05 Aug 2021 | San Diego, California, United States | ||
SiSaf | $13M | 26 Nov 2020 | Belfast, Northern Ireland, United Kingdom |
– Aardvark Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing novel small molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
– The company completed a $29m Series B financing.
– The round was led by Sorrento Therapeutics with participation from existing investors including Vickers Venture Partners, Premier Partners, BNH Investment, and Korea Omega.
– The funds raised will be deployed to advance the company’s pipeline of programs for metabolic diseases.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Mithradote Bio | 02 Oct 2024 | San Diego, California, United States | |||
Aardvark Therapeutics | $85M | 09 May 2024 | San Diego, California, United States | ||
Eavor | $144M | 25 Oct 2023 | Calgary, Canada | ||
AWAK Technologies | $20M | 13 Sep 2023 | Burbank, California, United States | ||
Eavor | $63M | 14 Jun 2023 | Calgary, Canada | ||
Qianyuhui Environmental Protection | 24 Nov 2022 | Dongcheng, Shaanxi, China | |||
RWDC Industries | $95M | 22 Nov 2021 | Singapore, Central, Singapore | ||
Aardvark Therapeutics | $29M | 05 Aug 2021 | San Diego, California, United States | ||
SiSaf | $13M | 26 Nov 2020 | Belfast, Northern Ireland, United Kingdom |